A project by the Asian Community AIDS Services

For feedback or questions, pls. email us at support@acas.org

Visit ACAS Support Pages

DRUG INFORMATION

Overview

General Approaches

Starting HIV Drugs

Participating in Clinical Trials

Immunizations

Treatment Interruptions

Adherence to Treatment

Changing Treatment

Post Exposure Prophylaxis (PEP)

Reverse Transcriptase Inhibitors

...3TC ..

...Abacavir ..

...AZT ..

...Combivir ..

...d4T ..

...ddC ..

...Delavirdine ..

...ddI ..

...Efavirenz ..

...Nevirapine ..

...Tenofovir ..

...Trizivir ..

Protease Inhibitors

...Amprenavir ..

...Atazanavir ..

...Indinavir ..

...Kaletra ..

...Nelfinavir ..

...Ritonavir ..

...Saquinavir ..

Fusion Inhibitors

...T-20 ..

Others

...Septra ..

HEALTH CONCERNS

.Bone Problems ..

.Candidiasis ..

. CMV Retinitis ..

.Diarrhea ..

.Hepatitis C ..

.HIV and Depression

.Lactic acidosis ..

.Lipodystrophy ..

.Lymphoma ..

.MAC ..

.Managing Side Effects ..

.PCP ..

.Peripheral Neuropathy ..

.Recreational Drugs and Anti-HIV Medications ..

.Safer Sex for HIV Positive People ..

.Sexual Dysfunction

.Tuberculosis ..

.Wasting ..

.Working effectively with Health Care Providers ..

MONITORING TESTS

.HIV Viral Load ..

.T-Cell Counts ..

.HIV Resistance Testing ..

.Common Blood Test

NUTRITION

.Eating Healthy ..

.Vitamins & Supplements..

WOMEN'S HEALTH

.Women & HIV ..

.HIV & Pregnancy ..

.Treatment Guidelines for Pregnant Women with HIV ..

COMPLEMENTARY THERAPIES

.Overview ..

.Planning ..